Taken together, O-GlcNAc glycosylation of ULK1 S409/S410 increases ULK1 stability by inhibiting ULK1 degradation via the CMA pathway, enhances autophagy, and improves the prognosis of HNSCC patients. Here, ULK1 is linked to head and neck squamous cell carcinoma.